Eyre, TA;
Osborne, WL;
Gallop-Evans, E;
Ardeshna, KM;
Kassam, S;
Sadullah, S;
Sidra, G;
Culligan, D;
Arumainathan, A;
Shankara, P;
et al.
Eyre, TA; Osborne, WL; Gallop-Evans, E; Ardeshna, KM; Kassam, S; Sadullah, S; Sidra, G; Culligan, D; Arumainathan, A; Shankara, P; Bowles, KM; Eyre, DW; Peng, YY; Pettengell, R; Bloor, A; Vandenberghe, E; Collins, GP
(2018)
Results of a multicentre UK-wide compassionate use programme evaluating the efficacy of idelalisib monotherapy in relapsed, refractory follicular lymphoma.
Br J Haematol, 181 (4).
pp. 555-559.
ISSN 1365-2141
https://doi.org/10.1111/bjh.14665
SGUL Authors: Pettengell, Ruth
|
PDF
Accepted Version
Available under License ["licenses_description_publisher" not defined]. Download (910kB) | Preview |
Item Type: | Article | ||||||
---|---|---|---|---|---|---|---|
Additional Information: | This is the peer reviewed version of the following article: Eyre, T. A., Osborne, W. L., Gallop‐Evans, E. , Ardeshna, K. M., Kassam, S. , Sadullah, S. , Sidra, G. , Culligan, D. , Arumainathan, A. , Shankara, P. , Bowles, K. M., Eyre, D. W., Peng, Y. Y., Pettengell, R. , Bloor, A. , Vandenberghe, E. and Collins, G. P. (2018), Results of a multicentre UK‐wide compassionate use programme evaluating the efficacy of idelalisib monotherapy in relapsed, refractory follicular lymphoma. Br J Haematol, 181: 555-559, which has been published in final form at https://doi.org/10.1111/bjh.14665. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions. | ||||||
Keywords: | PI3K, follicular lymphoma, idelalisib, Adult, Aged, Aged, 80 and over, Disease-Free Survival, Female, Follow-Up Studies, Humans, Lymphoma, Follicular, Male, Middle Aged, Purines, Quinazolinones, Recurrence, Survival Rate, United Kingdom, Humans, Lymphoma, Follicular, Recurrence, Purines, Disease-Free Survival, Survival Rate, Follow-Up Studies, Adult, Aged, Aged, 80 and over, Middle Aged, Female, Male, Quinazolinones, United Kingdom, follicular lymphoma, idelalisib, PI3K, 1102 Cardiovascular Medicine And Haematology, Immunology | ||||||
SGUL Research Institute / Research Centre: | Academic Structure > Institute of Medical & Biomedical Education (IMBE) Academic Structure > Institute of Medical & Biomedical Education (IMBE) > Centre for Clinical Education (INMECE ) |
||||||
Journal or Publication Title: | Br J Haematol | ||||||
ISSN: | 1365-2141 | ||||||
Language: | eng | ||||||
Dates: |
|
||||||
Publisher License: | Publisher's own licence | ||||||
PubMed ID: | 28342183 | ||||||
Web of Science ID: | WOS:000433566800020 | ||||||
Go to PubMed abstract | |||||||
URI: | https://openaccess.sgul.ac.uk/id/eprint/110247 | ||||||
Publisher's version: | https://doi.org/10.1111/bjh.14665 |
Statistics
Actions (login required)
Edit Item |